Bliss GVS Pharma has informed that it enclosed a certificate received from MUFG Intime India (Formerly known as Link Intime India), Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
The above information is a part of company’s filings submitted to BSE.